12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studies. [electronic resource]
Producer: 20160711Description: 864-8 p. digitalISSN:- 1878-3562
- Adult
- Aged
- Aged, 80 and over
- Albumins -- analysis
- Antiviral Agents -- administration & dosage
- Benzoates -- therapeutic use
- Female
- Hepacivirus
- Hepatitis C, Chronic -- complications
- Humans
- Hydrazines -- therapeutic use
- Interferon-alpha -- administration & dosage
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Multivariate Analysis
- Pyrazoles -- therapeutic use
- Ribavirin -- therapeutic use
- Risk Factors
- Severity of Illness Index
- Thrombocytopenia -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.